These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16010215)

  • 21. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2002.
    Commun Dis Intell Q Rep; 2003; 27(4):488-91. PubMed ID: 15508502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010.
    Unemo M; Golparian D; Hestner A
    Euro Surveill; 2011 Feb; 16(6):. PubMed ID: 21329645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibility among Neisseria gonorrhoeae in New Zealand in 2002.
    Heffernan H; Brokenshire M; Woodhouse R; MacCarthy A; Blackmore T
    N Z Med J; 2004 Apr; 117(1191):U817. PubMed ID: 15107886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
    Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
    Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial susceptibility and molecular epidemiology of Neisseria gonorrhoeae in Germany.
    Horn NN; Kresken M; Körber-Irrgang B; Göttig S; Wichelhaus C; Wichelhaus TA;
    Int J Med Microbiol; 2014 Jul; 304(5-6):586-91. PubMed ID: 24801146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, Canada.
    Martin I; Sawatzky P; Liu G; Allen V; Lefebvre B; Hoang L; Drews S; Horsman G; Wylie J; Haldane D; Garceau R; Ratnam S; Wong T; Archibald C; Mulvey MR
    Emerg Infect Dis; 2016 Jan; 22(1):65-7. PubMed ID: 26689114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can previous first-line therapies for Neisseria gonorrhoeae be targeted to specific patient subgroups to treat gonorrhea?
    Town K; Lowndes CM; Hughes G; Obi C; Chisholm S; Ison CA;
    Sex Transm Dis; 2015 Jan; 42(1):37-42. PubMed ID: 25504299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High prevalence of ciprofloxacin-resistant gonorrhea among female sex workers in Kampala, Uganda (2008-2009).
    Vandepitte J; Hughes P; Matovu G; Bukenya J; Grosskurth H; Lewis DA
    Sex Transm Dis; 2014 Apr; 41(4):233-7. PubMed ID: 24622633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluoroquinolone-resistant Neisseria gonorrhoeae in Bali, Indonesia: 2004.
    Donegan EA; Wirawan DN; Muliawan P; Schachter J; Moncada J; Parekh M; Knapp JS
    Sex Transm Dis; 2006 Oct; 33(10):625-9. PubMed ID: 16601661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.
    Morita-Ishihara T; Unemo M; Furubayashi K; Kawahata T; Shimuta K; Nakayama S; Ohnishi M
    J Antimicrob Chemother; 2014 Aug; 69(8):2086-90. PubMed ID: 24777907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae--Hawaii and California, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Nov; 51(46):1041-4. PubMed ID: 12487525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First line dual therapy for gonorrhoea to limit the spread of antimicrobial resistance.
    Mohammed H; Sile B; Furegato M; Woodhall S; Fifer H; Hughes G
    BMJ; 2017 Feb; 356():j565. PubMed ID: 28153820
    [No Abstract]   [Full Text] [Related]  

  • 33. Current and future treatment options for gonorrhoea.
    Ison CA; Deal C; Unemo M
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv52-6. PubMed ID: 24106339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is new with antibiotic-resistant gonorrhoea in Newcastle, England?
    Elawad BB; Narayanan M; Pattman RS; Sankar KN; Freeman R
    Int J STD AIDS; 2002 Dec; 13(12):805-8. PubMed ID: 12537730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in antimicrobial management of gonorrhoea by general practitioners in Amsterdam, the Netherlands, between 2010 and 2016: a cross-sectional study.
    van Amerongen R; Gazendam RP; van Bergen JEAM
    BMC Fam Pract; 2019 Jan; 20(1):12. PubMed ID: 30646849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An evaluation of Neisseria gonorrhoeae antimicrobial susceptibility testing in the UK.
    Jain A; Cole MJ; Planche T; Ison CA
    J Clin Pathol; 2014 Nov; 67(11):1013-6. PubMed ID: 25078330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in antimicrobial resistance in Neisseria gonorrhoeae in the USA: the Gonococcal Isolate Surveillance Project (GISP), January 2006-June 2012.
    Kirkcaldy RD; Kidd S; Weinstock HS; Papp JR; Bolan GA
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv5-10. PubMed ID: 24243881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Australian gonococcal surveillance programme, 1 April to 30 June 2014.
    Lahra MM;
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E390-2. PubMed ID: 25631604
    [No Abstract]   [Full Text] [Related]  

  • 39. Trends of resistance to antimicrobials recommended currently and in the past for management of gonorrhea in the Apex STD center in India and comparison of antimicrobial resistance profile between 2002-2006 and 2007-2012.
    Bala M; Singh V; Bhargava A; Ramesh V
    Sex Transm Dis; 2015 Apr; 42(4):218-22. PubMed ID: 25763675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rising trend of antimicrobial resistance among Neisseria gonorrhoeae isolates and the emergence of N. gonorrhoeae isolate with decreased susceptibility to ceftriaxone.
    Bharara T; Bhalla P; Rawat D; Garg VK; Sardana K; Chakravarti A
    Indian J Med Microbiol; 2015; 33(1):39-42. PubMed ID: 25560000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.